{
    "clinical_study": {
        "@rank": "132682", 
        "arm_group": [
            {
                "arm_group_label": "TAP Block Ropivacaine 0,75 %", 
                "arm_group_type": "Experimental", 
                "description": "Bilateral Transversus Abdominis Plane Block with 2 x 20 ml Ropivacaine 0,75 %"
            }, 
            {
                "arm_group_label": "TAP Block Saline 0,9 %", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Bilateral Transversus abdominis plane block with 2 x 20 ml Saline 0,9 %"
            }
        ], 
        "brief_summary": {
            "textblock": "A Prospective double-blinded randomized clinical trial to test the effect of transversus\n      abdominis plane block on postoperative pain and opoid consumption after abdominal\n      hysterectomy.\n\n      Two groups of each 24 patients. All patients are given general anesthesia. The patients are\n      randomized to have a ultrasound guided bilateral transversus abdominis plane block with\n      either 2 x 20 ml 0,75 % ropivacaine or 2 x 20 ml of 0,9 saline. All patients are provided\n      with a PCA for self administration of morphine.\n\n      Pain score on visual analog scale, nausea and vomiting are monitored at 1, 2, 4, 6, 8 and 24\n      hours postoperatively as well as the total consumption of morphine after 24 hours."
        }, 
        "brief_title": "Ultrasound Guided Transversus Abdominis Plane Block With Ropivacaine vs Placebo for Abdominal Hysterectomy: a Double-blinded, Randomized Clinical Trial", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Postoperative Pain and Postoperative Morphine Consumption After Abdominal Hysterectomy", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Assigned to elective abdominal hysterectomy\n\n          -  Must be able to understand and speak danish\n\n          -  Must be able to give verbal and written consent\n\n        Exclusion Criteria:\n\n          -  Abuse of alcohol or medicin\n\n          -  Daily treatment with opoids or glucocorticoids\n\n          -  Allergy towards any kind of localanesthetic drug\n\n          -  Intolerance toward morphine\n\n          -  Psychiatric desease\n\n          -  Age below 18"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01743378", 
            "org_study_id": "H-1-2010-068"
        }, 
        "intervention": [
            {
                "arm_group_label": "TAP Block Ropivacaine 0,75 %", 
                "intervention_name": "TAP Block Ropivacaine 0,75 %", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "TAP Block Saline 0,9 %", 
                "intervention_name": "TAP Block Saline 0,9 %", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hvidovre", 
                    "country": "Denmark", 
                    "state": "Hovedstaden", 
                    "zip": "2650"
                }, 
                "name": "Hvidovre Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Ultrasound Guided Transversus Abdominis Plane Block With Ropivacaine vs Placebo for Abdominal Hysterectomy: a Double-blinded, Randomized Clinical Trial", 
        "other_outcome": [
            {
                "description": "Monitored at 1, 2, 4, 6, 8 and 24 hours postoperatively by one of the investigators", 
                "measure": "Postoperative nausea and vomiting", 
                "safety_issue": "No", 
                "time_frame": "Monitored at 1, 2, 4, 6, 8 and 24 hours postoperatively"
            }, 
            {
                "description": "Length of hospital stay counted in days", 
                "measure": "Length of stay", 
                "safety_issue": "No", 
                "time_frame": "First 72 hours after surgery"
            }, 
            {
                "description": "First mobilization defined as walking on the floor", 
                "measure": "Time until mobilization", 
                "safety_issue": "No", 
                "time_frame": "First 24 hours postoperatively"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Ethics Committee", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Total morphine consumption during first 24 hours postoperatively", 
            "safety_issue": "No", 
            "time_frame": "At 24 hours postoperatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01743378"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hvidovre University Hospital", 
            "investigator_full_name": "Billy B Kristensen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Monitored at 1, 2, 4, 6, 8 and 24 hours postoperatively by one of the investigators at rest, when coughing and when walking", 
            "measure": "Postoperative pain by visual analog scale at", 
            "safety_issue": "No", 
            "time_frame": "Monitored at 1, 2, 4, 6, 8 and 24 hours postoperatively"
        }, 
        "source": "Hvidovre University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hvidovre University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}